United States Human Immune Globulin Intravenous Market Report 2018

March 2018 | 107 pages | ID: U7878E4717CEN
QYResearch

Abstracts

In this report, the United States Human Immune Globulin Intravenous market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Human Immune Globulin Intravenous in these regions, from 2013 to 2025 (forecast).

United States Human Immune Globulin Intravenous market competition by top manufacturers/players, with Human Immune Globulin Intravenous sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Baxter
• Grifols
• CSL
• Octapharma
• Biotest
• Kedrion
• Hualan Bio
• CNBG
• Shanghai RAAS
• CBPO
• LFB Group
• BPL
• Sichuan Yuanda Shuyang

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• IVIg Liquid
• IVIg Powder

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Immunodeficiency
• Autoimmune Disease
• Acute Infection

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Human Immune Globulin Intravenous Market Report 2018

1 HUMAN IMMUNE GLOBULIN INTRAVENOUS OVERVIEW

1.1 Product Overview and Scope of Human Immune Globulin Intravenous
1.2 Classification of Human Immune Globulin Intravenous by Product Category
  1.2.1 United States Human Immune Globulin Intravenous Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Human Immune Globulin Intravenous Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 IVIg Liquid
  1.2.4 IVIg Powder
1.3 United States Human Immune Globulin Intravenous Market by Application/End Users
  1.3.1 United States Human Immune Globulin Intravenous Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Immunodeficiency
  1.3.3 Autoimmune Disease
  1.3.4 Acute Infection
1.4 United States Human Immune Globulin Intravenous Market by Region
  1.4.1 United States Human Immune Globulin Intravenous Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Human Immune Globulin Intravenous Status and Prospect (2013-2025)
  1.4.3 Southwest Human Immune Globulin Intravenous Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Human Immune Globulin Intravenous Status and Prospect (2013-2025)
  1.4.5 New England Human Immune Globulin Intravenous Status and Prospect (2013-2025)
  1.4.6 The South Human Immune Globulin Intravenous Status and Prospect (2013-2025)
  1.4.7 The Midwest Human Immune Globulin Intravenous Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Human Immune Globulin Intravenous (2013-2025)
  1.5.1 United States Human Immune Globulin Intravenous Sales and Growth Rate (2013-2025)
  1.5.2 United States Human Immune Globulin Intravenous Revenue and Growth Rate (2013-2025)

2 UNITED STATES HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Human Immune Globulin Intravenous Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Human Immune Globulin Intravenous Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Human Immune Globulin Intravenous Average Price by Players/Suppliers (2013-2018)
2.4 United States Human Immune Globulin Intravenous Market Competitive Situation and Trends
  2.4.1 United States Human Immune Globulin Intravenous Market Concentration Rate
  2.4.2 United States Human Immune Globulin Intravenous Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Human Immune Globulin Intravenous Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HUMAN IMMUNE GLOBULIN INTRAVENOUS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Human Immune Globulin Intravenous Sales and Market Share by Region (2013-2018)
3.2 United States Human Immune Globulin Intravenous Revenue and Market Share by Region (2013-2018)
3.3 United States Human Immune Globulin Intravenous Price by Region (2013-2018)

4 UNITED STATES HUMAN IMMUNE GLOBULIN INTRAVENOUS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Human Immune Globulin Intravenous Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Human Immune Globulin Intravenous Revenue and Market Share by Type (2013-2018)
4.3 United States Human Immune Globulin Intravenous Price by Type (2013-2018)
4.4 United States Human Immune Globulin Intravenous Sales Growth Rate by Type (2013-2018)

5 UNITED STATES HUMAN IMMUNE GLOBULIN INTRAVENOUS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Human Immune Globulin Intravenous Sales and Market Share by Application (2013-2018)
5.2 United States Human Immune Globulin Intravenous Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES HUMAN IMMUNE GLOBULIN INTRAVENOUS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Baxter
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Immune Globulin Intravenous Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Baxter Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Grifols
  6.2.2 Human Immune Globulin Intravenous Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Grifols Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 CSL
  6.3.2 Human Immune Globulin Intravenous Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CSL Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Octapharma
  6.4.2 Human Immune Globulin Intravenous Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Octapharma Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Biotest
  6.5.2 Human Immune Globulin Intravenous Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biotest Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Kedrion
  6.6.2 Human Immune Globulin Intravenous Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Kedrion Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Hualan Bio
  6.7.2 Human Immune Globulin Intravenous Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Hualan Bio Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 CNBG
  6.8.2 Human Immune Globulin Intravenous Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 CNBG Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Shanghai RAAS
  6.9.2 Human Immune Globulin Intravenous Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Shanghai RAAS Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 CBPO
  6.10.2 Human Immune Globulin Intravenous Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 CBPO Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 LFB Group
6.12 BPL
6.13 Sichuan Yuanda Shuyang

7 HUMAN IMMUNE GLOBULIN INTRAVENOUS MANUFACTURING COST ANALYSIS

7.1 Human Immune Globulin Intravenous Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Immune Globulin Intravenous

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Immune Globulin Intravenous Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Immune Globulin Intravenous Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Human Immune Globulin Intravenous Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Human Immune Globulin Intravenous Sales Volume Forecast by Type (2018-2025)
11.3 United States Human Immune Globulin Intravenous Sales Volume Forecast by Application (2018-2025)
11.4 United States Human Immune Globulin Intravenous Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Immune Globulin Intravenous
Figure United States Human Immune Globulin Intravenous Market Size (K Units) by Type (2013-2025)
Figure United States Human Immune Globulin Intravenous Sales Volume Market Share by Type (Product Category) in 2017
Figure IVIg Liquid Product Picture
Figure IVIg Powder Product Picture
Figure United States Human Immune Globulin Intravenous Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Human Immune Globulin Intravenous by Application in 2017
Figure Immunodeficiency Examples
Table Key Downstream Customer in Immunodeficiency
Figure Autoimmune Disease Examples
Table Key Downstream Customer in Autoimmune Disease
Figure Acute Infection Examples
Table Key Downstream Customer in Acute Infection
Figure United States Human Immune Globulin Intravenous Market Size (Million USD) by Region (2013-2025)
Figure The West Human Immune Globulin Intravenous Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Human Immune Globulin Intravenous Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Human Immune Globulin Intravenous Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Human Immune Globulin Intravenous Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Human Immune Globulin Intravenous Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Human Immune Globulin Intravenous Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2025)
Figure United States Human Immune Globulin Intravenous Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Human Immune Globulin Intravenous Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Human Immune Globulin Intravenous Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Human Immune Globulin Intravenous Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Human Immune Globulin Intravenous Sales Share by Players/Suppliers
Figure 2017 United States Human Immune Globulin Intravenous Sales Share by Players/Suppliers
Figure United States Human Immune Globulin Intravenous Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Human Immune Globulin Intravenous Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Human Immune Globulin Intravenous Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Human Immune Globulin Intravenous Revenue Share by Players/Suppliers
Figure 2017 United States Human Immune Globulin Intravenous Revenue Share by Players/Suppliers
Table United States Market Human Immune Globulin Intravenous Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Human Immune Globulin Intravenous Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Human Immune Globulin Intravenous Market Share of Top 3 Players/Suppliers
Figure United States Human Immune Globulin Intravenous Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Human Immune Globulin Intravenous Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Human Immune Globulin Intravenous Product Category
Table United States Human Immune Globulin Intravenous Sales (K Units) by Region (2013-2018)
Table United States Human Immune Globulin Intravenous Sales Share by Region (2013-2018)
Figure United States Human Immune Globulin Intravenous Sales Share by Region (2013-2018)
Figure United States Human Immune Globulin Intravenous Sales Market Share by Region in 2017
Table United States Human Immune Globulin Intravenous Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Human Immune Globulin Intravenous Revenue Share by Region (2013-2018)
Figure United States Human Immune Globulin Intravenous Revenue Market Share by Region (2013-2018)
Figure United States Human Immune Globulin Intravenous Revenue Market Share by Region in 2017
Table United States Human Immune Globulin Intravenous Price (USD/Unit) by Region (2013-2018)
Table United States Human Immune Globulin Intravenous Sales (K Units) by Type (2013-2018)
Table United States Human Immune Globulin Intravenous Sales Share by Type (2013-2018)
Figure United States Human Immune Globulin Intravenous Sales Share by Type (2013-2018)
Figure United States Human Immune Globulin Intravenous Sales Market Share by Type in 2017
Table United States Human Immune Globulin Intravenous Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Human Immune Globulin Intravenous Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Human Immune Globulin Intravenous by Type (2013-2018)
Figure Revenue Market Share of Human Immune Globulin Intravenous by Type in 2017
Table United States Human Immune Globulin Intravenous Price (USD/Unit) by Types (2013-2018)
Figure United States Human Immune Globulin Intravenous Sales Growth Rate by Type (2013-2018)
Table United States Human Immune Globulin Intravenous Sales (K Units) by Application (2013-2018)
Table United States Human Immune Globulin Intravenous Sales Market Share by Application (2013-2018)
Figure United States Human Immune Globulin Intravenous Sales Market Share by Application (2013-2018)
Figure United States Human Immune Globulin Intravenous Sales Market Share by Application in 2017
Table United States Human Immune Globulin Intravenous Sales Growth Rate by Application (2013-2018)
Figure United States Human Immune Globulin Intravenous Sales Growth Rate by Application (2013-2018)
Table Baxter Basic Information List
Table Baxter Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Baxter Human Immune Globulin Intravenous Sales Growth Rate (2013-2018)
Figure Baxter Human Immune Globulin Intravenous Sales Market Share in United States (2013-2018)
Figure Baxter Human Immune Globulin Intravenous Revenue Market Share in United States (2013-2018)
Table Grifols Basic Information List
Table Grifols Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Grifols Human Immune Globulin Intravenous Sales Growth Rate (2013-2018)
Figure Grifols Human Immune Globulin Intravenous Sales Market Share in United States (2013-2018)
Figure Grifols Human Immune Globulin Intravenous Revenue Market Share in United States (2013-2018)
Table CSL Basic Information List
Table CSL Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CSL Human Immune Globulin Intravenous Sales Growth Rate (2013-2018)
Figure CSL Human Immune Globulin Intravenous Sales Market Share in United States (2013-2018)
Figure CSL Human Immune Globulin Intravenous Revenue Market Share in United States (2013-2018)
Table Octapharma Basic Information List
Table Octapharma Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Octapharma Human Immune Globulin Intravenous Sales Growth Rate (2013-2018)
Figure Octapharma Human Immune Globulin Intravenous Sales Market Share in United States (2013-2018)
Figure Octapharma Human Immune Globulin Intravenous Revenue Market Share in United States (2013-2018)
Table Biotest Basic Information List
Table Biotest Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biotest Human Immune Globulin Intravenous Sales Growth Rate (2013-2018)
Figure Biotest Human Immune Globulin Intravenous Sales Market Share in United States (2013-2018)
Figure Biotest Human Immune Globulin Intravenous Revenue Market Share in United States (2013-2018)
Table Kedrion Basic Information List
Table Kedrion Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Kedrion Human Immune Globulin Intravenous Sales Growth Rate (2013-2018)
Figure Kedrion Human Immune Globulin Intravenous Sales Market Share in United States (2013-2018)
Figure Kedrion Human Immune Globulin Intravenous Revenue Market Share in United States (2013-2018)
Table Hualan Bio Basic Information List
Table Hualan Bio Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hualan Bio Human Immune Globulin Intravenous Sales Growth Rate (2013-2018)
Figure Hualan Bio Human Immune Globulin Intravenous Sales Market Share in United States (2013-2018)
Figure Hualan Bio Human Immune Globulin Intravenous Revenue Market Share in United States (2013-2018)
Table CNBG Basic Information List
Table CNBG Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CNBG Human Immune Globulin Intravenous Sales Growth Rate (2013-2018)
Figure CNBG Human Immune Globulin Intravenous Sales Market Share in United States (2013-2018)
Figure CNBG Human Immune Globulin Intravenous Revenue Market Share in United States (2013-2018)
Table Shanghai RAAS Basic Information List
Table Shanghai RAAS Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shanghai RAAS Human Immune Globulin Intravenous Sales Growth Rate (2013-2018)
Figure Shanghai RAAS Human Immune Globulin Intravenous Sales Market Share in United States (2013-2018)
Figure Shanghai RAAS Human Immune Globulin Intravenous Revenue Market Share in United States (2013-2018)
Table CBPO Basic Information List
Table CBPO Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CBPO Human Immune Globulin Intravenous Sales Growth Rate (2013-2018)
Figure CBPO Human Immune Globulin Intravenous Sales Market Share in United States (2013-2018)
Figure CBPO Human Immune Globulin Intravenous Revenue Market Share in United States (2013-2018)
Table LFB Group Basic Information List
Table BPL Basic Information List
Table Sichuan Yuanda Shuyang Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Immune Globulin Intravenous
Figure Manufacturing Process Analysis of Human Immune Globulin Intravenous
Figure Human Immune Globulin Intravenous Industrial Chain Analysis
Table Raw Materials Sources of Human Immune Globulin Intravenous Major Players/Suppliers in 2017
Table Major Buyers of Human Immune Globulin Intravenous
Table Distributors/Traders List
Figure United States Human Immune Globulin Intravenous Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Human Immune Globulin Intravenous Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Human Immune Globulin Intravenous Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Human Immune Globulin Intravenous Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Human Immune Globulin Intravenous Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Human Immune Globulin Intravenous Sales Volume (K Units) Forecast by Type in 2025
Table United States Human Immune Globulin Intravenous Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Human Immune Globulin Intravenous Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Human Immune Globulin Intravenous Sales Volume (K Units) Forecast by Application in 2025
Table United States Human Immune Globulin Intravenous Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Human Immune Globulin Intravenous Sales Volume Share Forecast by Region (2018-2025)
Figure United States Human Immune Globulin Intravenous Sales Volume Share Forecast by Region (2018-2025)
Figure United States Human Immune Globulin Intravenous Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources